Company Filing History:
3 out of 1,744 
1 out of 5 
1 out of 832,718 Years Active: 2003-2016
Title: Thomas E Witzig: Innovator in Medical Research
Introduction
Thomas E Witzig is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in the treatment of various diseases. With a total of 4 patents, Witzig's work has had a profound impact on healthcare.
Latest Patents
Witzig's latest patents include innovative methods for depleting immunosuppressive monocytes within a mammal. This patent outlines the use of a CD2 binding molecule, such as alefacept, to effectively deplete these monocytes in humans. Another significant patent focuses on a method of treating mantle cell lymphoma, utilizing rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) for treatment or inhibition of this type of cancer.
Career Highlights
Throughout his career, Witzig has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and Agri-King, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Witzig has collaborated with notable colleagues, including David A Spangler and Patrick K Brown. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical research.
Conclusion
Thomas E Witzig's contributions to medical research through his patents and collaborations highlight his dedication to improving healthcare. His innovative approaches continue to pave the way for advancements in treatment methodologies.